C, E. et al. 2019. PREVALANE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Journal of the ASEAN Federation of Endocrine Societies. 34, (Jul. 2019), 21.